Pharmaceutical Sector

An FDA Advisory Panel Approves Acadia’s Parkinson’s Antipsychotic Drug

An advisory panel to the U. S. FDA (Food and Drug Administration) rendered their support for Acadia Pharmaceuticals Inc's, Nuplazid; a drug for psychosis related to Parkinson's disease. Approximately forty percent of patients suffering from the condition experience Psychosis, which is characterized by hallucinations and delusions.

According to the panel, the benefits of Nuplazid outweighed its risks. Twelve members in the panel out voted two, in favor of the treatment.

Valeant Shares Drop with News of Possible Earnings Restatement

Valeant Pharmaceuticals International Inc, based in Laval, Canada has been facing a tough time since questions were raised regarding its accounting practices and its relation with Philidor Rx Services LLC, a mail-order pharmacy service provider.

People who have knowledge of the matter said, Valeant is expected to restate some of its past earnings limited to results from 2014 and 2015.

University of California at Davis and Moffitt Cancer Center in Florida Suspends Trial of Drug to be Funded by KaloBios Drug Following CEO’s Arrest

University of California at Davis and Moffitt Cancer Center in Florida Suspends Trial of Drug to be Funded by KaloBios Drug Following CEO’s ArrestA clinical trial which was to be funded by KaloBios Pharmaceuticals Inc. has been suspended by the University of California at Davis and Moffitt Cancer Center in Florida as the pharma company's CEO Martin Shkreli was arrested on Thursday on charges of securities fraud.

Pfizer’s deal with Allergan not Making Americans Happy

PfizerThe year is about to end and some deals in the pharmaceutical companies is keeping the market alive bringing in controversies. It’s none other than Pfizer’s $152 billion deal with Allergan.

Third Quarter Earnings Report of CVS Health Misses Analysts’ Expectations

Third Quarter Earnings Report of CVS Health Misses Analysts’ ExpectationsThree months back the shares of CVS Health had hit an all-time high, but on Friday, they tumbled as the profit forecast for 2016 by the company could not meet the expectations of the market.

The Woonsocket, Rhode Island based company that operates more than 7,700 CVS Pharmacy and Longs Drugs stores gave a detail of the Q3 earnings which also missed the expectations of the analysts'.

AstraZeneca sells Global Right’s of Entocort Outside U.S to Tillotts Pharma

AstraZeneca sells Global Right’s of Entocort Outside U.S to Tillotts PharmaOn Thursday, British drug manufacturer AstraZeneca PLC said that in a deal of $215 million it is selling Tillotts Pharma AG the global rights of its Crohn's disease medicine. The rights of the medicine in the U.S will remain with AstraZeneca.

Pages